Products
Platform
Research
Market
Learn
Senores Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 167.17 | 141.35 | 125.98 | 108.18 | 102.49 |
| Other Income Qtr Cr | 5.41 | 3.36 | 11.77 | 5.16 | 1.86 |
| Operating Revenues Qtr | 161.76 | 137.99 | 114.21 | 103.02 | 100.63 |
Loading chart... | |||||
Operating Expenses Qtr | 112.26 | 103.83 | 94.77 | 77.33 | 77.38 |
Operating Profit Qtr | 49.50 | 34.16 | 19.44 | 25.69 | 23.25 |
EBITDA Qtr Cr | 54.91 | 37.52 | 31.21 | 30.85 | 25.11 |
Depreciation Qtr | 8.09 | 5.99 | 5.23 | 4.20 | 3.89 |
Net Profit Qtr | 32.38 | 19.73 | 17.83 | 17.18 | 12.83 |
Basic EPS Qtr | 6.54 | 4.60 | 3.81 | 5.04 | 3.92 |
Open Demat Account
Open Demat Account